北京华素制药股份有限公司377.15万股股份（3.572%股权） |
| 时间：2022-09-08 21:44:45 来源： 作者： |
| {"holderlist":{"utrgcemsshareholder":[{"createtime":"2022-09-08 21:44:45.000","id":"69242-104979","holderno":"1","pch":"104979","lastupdatetime":"2023-01-29 00:12:09.902","holdername":"北京中关村四环医药开发有限贵任公司","projectid":"228079","holdingratio":"94.214","objectid":"228079","holderid":"69242","recordtype":"A00001"}, {"createtime":"2022-09-08 21:44:45.000","id":"69243-104979","holderno":"2","pch":"104979","lastupdatetime":"2023-01-29 00:12:09.902","holdername":"北京工业发展投资管理有限公司","projectid":"228079","holdingratio":"3.572","objectid":"228079","holderid":"69243","recordtype":"A00001"}, {"createtime":"2022-09-08 21:44:45.000","id":"69245-104979","holderno":"3","pch":"104979","lastupdatetime":"2023-01-29 00:12:09.902","holdername":"北京锦绣大地农业股份有限公司","projectid":"228079","holdingratio":"0.738","objectid":"228079","holderid":"69245","recordtype":"A00001"}, {"createtime":"2022-09-08 21:44:45.000","id":"69246-104979","holderno":"4","pch":"104979","lastupdatetime":"2023-01-29 00:12:09.902","holdername":"北京万维医药有限公司","projectid":"228079","holdingratio":"0.738","objectid":"228079","holderid":"69246","recordtype":"A00001"}, {"createtime":"2022-09-08 21:44:45.000","id":"69244-104979","holderno":"5","pch":"104979","lastupdatetime":"2023-01-29 00:12:09.902","holdername":"田丹","projectid":"228079","holdingratio":"0.738","objectid":"228079","holderid":"69244","recordtype":"A00001"}]},"sellerlist":{"utrgcemsseller":[{"hqcode":"911100004005921645","heldshares":"3771500","authorizefilename":"北京市国有资产经营有限责任公司关于同意北工投资转让所持华素制药股权的批复","sellerid":"13838","zonezw":"北京市东城区隆福寺街95号钱粮胡同38号2幢6层B601-1","approvalagency":"集团（控股）公司","createtime":"2022-09-08 21:44:45.000","id":"13838-104979","estabdate":"2002-02-28","sellertype":"A11001","economynature":"A19002","paidfunding":"100000.00万元(人民币)","gyfgylx":"0","sellername":"北京工业发展投资管理有限公司","projectid":"228079","regcapcurrency":"RMB","recordtype":"A00001","monitorname":"A02003","legalcontact":"逯嘉","sellerstockpercent":"3.572","pch":"104979","industrycodezw":"商务服务业","sharesunit":"1","managerscale":"A04003","gyzbczlx":"2","sellpercent":"3.572","zonecountyzw":"东城区","objectboss":"张涛","hqname":"北京市国有资产经营有限责任公司","authorizefiletype":"A07004","industrycode":"L72","authorizeunit":"北京市国有资产经营有限责任公司","decisionfiletype":"A07002","monitorzone":"110000","sellercode":"91110000735110091R","lastupdatetime":"2023-01-29 00:12:09.892","authorizedate":"2022-09-02","zoneprovincezw":"北京市","transfershares":"3771500","economytype":"A05002","licenseenddate":"2027-02-28","regcapital":"100000","legalcontactphone":"13901037409","registeredcapital":"100000.00万元(人民币)","zone":"110101"}]},"utrgcemsproject":{"projecttype":"G3","projectcode":"G32022BJ1000583","publishdate":"2022-09-14","sfplzcpgqk":"0","procontactmobile":"83143107","objectprice":"6068.50万元","recordtype":"A00001","pch":"104979","workingday":"2","bdsfsycmcp":"0","procontact":"许菲","shtgsj":"2022-09-13 17:18:23","sfwwxs":"0","procontactphone":"13522017121","bjhlpuburl":"https://otc.cbex.com/cgq/detail/228079.html","businessstatus":"A01001","expiredate":"2023-02-02","object":"北京华素制药股份有限公司377.15万股股份（3.572%股权）","id":"14044-104979","createtime":"2022-09-08 21:44:45.000","zonecity":"110100","workingxs":"120秒","projectid":"228079","istransferofctrl":"F","notcollectdesc":"延长信息披露：不变更信息披露内容，按照5个工作日为一个周期延长，直至征集到意向受让方。","sfxshybl":"0","workingrmb":"万元","isbind":"F","deptcontactmobile":"010-66295656","releaselevel":"0","duration":"20","lastupdatetime":"2023-01-29 00:12:09.872","deptcontact":"李响"},"utrgcemsobject":{"zonecounty":"北京市房山区良乡镇工业开发区金光北街1号","stmtprofit":"6283.28","approvedate":"2022-09-01","stmtnetprofit":"6283.55","economynature":"A19003","stmtdebt":"42037.37","paidfunding":"10560.05万元(人民币)","jzrsjjg":"大华会计师事务所（特殊普通合伙）","recordtype":"A00001","auditequity":"98171.97","auditearning":"78446.31","pch":"104979","auditunit":"大华会计师事务所（特殊普通合伙）","industrycodezw":"医药制造业","stmtearning":"16876.43","audityear":"2021","sellpercent":"3.572","bookdebt":"42402.0143","zonecountyzw":"房山区","stmtgrossprofit":"6270.08","auditdebt":"62829.54","decisionfiletype":"A07003","evaluateunit":"北京中天华资产评估有限责任公司","objectid":"228079","registeredcapital":"10560.05万元(人民币)","bookequity":"80628.8043","evaluateequity":"169890","auditgrossprofit":"8112.79","employeequantity":"400","auditprofit":"8015.49","objectevaluatevalue":"6068.4708","approveunit":"北京市国有资产经营有限责任公司","stmttype":"月报","stmtequity":"90694.29","objectname":"北京华素制药股份有限公司","id":"14044-104979","createtime":"2022-09-08 21:44:45.000","estabdate":"2000-06-28","zonecity":"110100","hascontainground":"F","projectid":"228079","bookasset":"123030.8186","stmtasset":"132731.66","auditasset":"161001.51","auditnetprofit":"6698.94","managerscale":"A04002","businessscope":"外用制剂、片剂、注射剂、胶囊制剂、口服溶液剂、麻醉药品制造；原料药（仅限外埠制造）；外用制剂、片剂、注射剂、原料药、胶囊制剂、口服溶液剂、麻醉药品的技术开发；销售化妆品、口腔清洁用品；货物进出口（国营贸易管理货物除外）、技术进出口、代理进出口。（企业依法自主选择经营项目，开展经营活动；依法须经批准的项目，经相关部门批准后依批准的内容开展经营活动；不得从事本市产业政策禁止和限制类项目的经营活动。）","zoneprovince":"110000","objectboss":"侯占军","stmtdate":"2022-07-31","industrycode":"C27","objectcode":"911100007226097157","lastupdatetime":"2023-01-29 00:12:09.897","zoneprovincezw":"北京市","economytype":"A05006","evaluatedate":"2021-12-31","zone":"110111"},"utrgcemspubinfo":{"importantinfo":"1.评估报告中特别事项说明提醒意向受让方重点关注。\n2.具体信息详见资产评估报告、审计报告等北京产权交易所备查文件。","ypsj":"2023-01-29 00:01:00","moneypaytype":"一次性支付","baildate":"意向受让方经资格确认后3个工作日内交纳。","createtime":"2022-09-08 21:44:45.000","id":"14044-104979","isbail":"1","hasbuyintent":"F","biddingmethod":"多次报价","sellconditions":"1.意向受让方经资格确认后3个工作日内须向北京产权交易所指定账户交纳1800万元的交易保证金（以到账时间为准）。信息披露公告期满后，根据意向受让方的征集情况，按照《北京产权交易所企业国有产权转让操作规则》、《北京产权交易所企业国有产权转让登记受让意向操作细则》、《北京产权交易所企业国有产权转让交易保证金操作细则》、《北京产权交易所企业国有产权转让股东行使优先购买权操作细则》等规定进行后续操作。\n2.当最高报价方或受让方确定后，未涉及扣除保证金情形的其他意向受让方所交纳的交易保证金将无息返还。受让方交纳的保证金可以直接转为交易价款的一部分。\n3.若非转让方原因，出现以下任何一种情况时，意向受让方所交纳的交易保证金将被扣除，先用于补偿北京产权交易所应收取的各项服务费，剩余部分作为转让方经济补偿费，保证金不足以弥补给相关方造成的损失的，相关方可继续追偿：（1）意向受让方交纳交易保证金后单方撤回受让申请的；（2）征集到2家及以上符合条件的意向受让方后，未参与后续竞价程序的；（3）在竞价过程中以转让底价为起始价，各意向受让方均不应价的；（4）在确定为受让方后未在5个工作日内与转让方签订《产权交易合同》或未在《产权交易合同》生效后5个工作日内支付剩余交易价款或交易服务费的；（5）意向受让方存在其他违反交易规则、挂牌条件要求的。\n4.意向受让方须对以下事项书面承诺:（1）同意自被确定为受让方后5个工作日内与转让方签订《产权交易合同》；（2）在《产权交易合同》生效后5个工作日内一次性将除保证金以外的剩余交易价款及交易服务费支付至北京产权交易所指定账户；（2）在通过资格确认并交纳保证金后，即视为已详细阅读并完全认可本股权转让项目所涉审计报告、资产评估报告及该等文件所披露内容，并依据该等内容以其独立判断决定自愿全部接受产权转让公告之内容；支付保证金后，不以不了解标的企业债权债务、资产状况等原因终止项目成交工作的推进，否则将同意转让方全额扣除已支付至北京产权交易所的保证金。\n5.本股权转让挂牌公告期即为尽职调查期，意向受让方递交受让申请并且交纳交易保证金，即视为已经详细阅读并完全认可本转让标的披露的内容，并依据该等内容以其独立判断决定自愿全部接受产权转让公告之内容。","projectid":"228079","employeesettle":"F","recordtype":"A00001","pch":"104979","pubexchangetype":"A10004","announcemethod":"A16002","buyerpostulate":"无","lastupdatetime":"2023-01-29 00:12:09.903","projectlinkurl":"https://otc.cbex.com/cgq/detail/228079.html","giveuppriority":"T","ismixed":"0","pubid":"228079","bailprice":"1800"}} |
|
|
|
